Eli Lilly Scores $375M For COVID-19 Treatment
The federal government said it has agreed to pay $375 million for an experimental Eli Lilly and Co. treatment to combat COVID-19, not long after the company said hospitalized patients would...To view the full article, register now.
Already a subscriber? Click here to view full article